Moreover, in clinically advanced patients, CD4+/CD8+ ratio and LMR decreased, while CD8+T cells levels increased, indicating that different immune cells within the CD8+T cells may play an inconsistent role at different stages of tumor progression. This evidence concerns the gene CD4 and neoplasm.